The £3 million Tumour Profiling Unit (TPU) in London is to research the use of DNA mapping to identify patients' cancer strains. It is hoped the technique will pave the way for radical new forms of diagnosis, surveillance and targeted therapy.
One aim of the research is to develop "liquid biopsies" that search for free-floating cancer DNA in samples of blood. This can then be used to identify and monitor cancer sub-types that are likely to respond to particular drugs.
Another, controversial, proposal is the use of "mouse avatars" that mirror a patient's disease progression.
Tumour samples from patients will be implanted into mice which will then be observed closely to spot early signs of molecular change and resistance to therapy.
More top news
Cross-channel services face the possibility of ongoing disruption because of migrant activity in and around Calais.
Big companies will have to show that their supply chains do not use child slave labour or exploit people, David Cameron has announced.
Disneyland Paris is reportedly facing a pricing probe amid claims it charges British tourists more than its French customers.